Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: LTK007 who wrote (18209)	7/29/1999 10:24:00 AM
From: Maarten Z	Respond to of 56535

FDA plays seem to be the ones lately Was looking for them on the wire and saw CSON but figured - so what a hemostat! Of course its up now as anything with FDA in the headline is being played. MZ

To: LTK007 who wrote (18209)	7/29/1999 10:30:00 AM
From: Wes Stevens	Read Replies (1) \| Respond to of 56535

This looks interesting: 10:08 ET Cohesion Technologies (CSON) 5 1/4 +1 1/8 (+27%): Company announces that FDA has granted fast-track review of company's a liquid hemostat designed to stop or control surgical bleeding. CSON informed that an advisory panel hearing will not be required. Company originally anticipated the review process, including a panel meeting, could take approximately one year. Volume 111K; intraday range 4 9/16 to 5 1/2. I have a bid in at 5 1/2. At 6 currently. Hoping it will pull back and then run.